New heart failure drug shows promise in Real-World chinese study
NCT ID NCT05728502
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study collected data from 2,400 Chinese adults with chronic heart failure to see how well the drug vericiguat works compared to standard care. The main goal was to see if vericiguat could prevent death from heart problems or hospital stays due to heart failure. Researchers also tracked side effects to understand the drug's safety in everyday use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chinese Registries
Multiple Locations, Many Locations, China
Conditions
Explore the condition pages connected to this study.